News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
847,362 Results
Type
Article (86520)
Company Profile (702)
Press Release (760140)
Multimedia
Podcasts (131)
Webinars (14)
Section
Business (232696)
Career Advice (4128)
Deals (39721)
Drug Delivery (129)
Drug Development (90990)
Employer Resources (198)
FDA (18114)
Job Trends (17340)
News (396489)
Policy (39752)
Tag
Academia (3000)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (96)
Alliances (56842)
ALS (106)
Alzheimer's disease (1507)
Antibody-drug conjugate (ADC) (164)
Approvals (18069)
Artificial intelligence (335)
Autoimmune disease (30)
Automation (17)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (481)
Bladder cancer (86)
Brain cancer (32)
Breast cancer (315)
Cancer (2497)
Cardiovascular disease (210)
Career advice (3535)
Career pathing (34)
CAR-T (177)
Cell therapy (502)
Cervical cancer (22)
Clinical research (73490)
Collaboration (936)
Company closure (2)
Compensation (586)
Complete response letters (30)
COVID-19 (2869)
CRISPR (50)
C-suite (275)
Cystic fibrosis (109)
Data (2383)
Decentralized trials (2)
Denatured (46)
Depression (57)
Diabetes (303)
Diagnostics (6931)
Digital health (21)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (152)
Drug pricing (131)
Drug shortages (33)
Duchenne muscular dystrophy (104)
Earnings (97038)
Editorial (47)
Employer branding (25)
Employer resources (167)
Events (130260)
Executive appointments (788)
FDA (19555)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (835)
Gene editing (125)
Generative AI (35)
Gene therapy (369)
GLP-1 (863)
Government (5172)
Grass and pollen (6)
Guidances (156)
Healthcare (20891)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (153)
Indications (30)
Infectious disease (3034)
Inflammatory bowel disease (159)
Inflation Reduction Act (11)
Influenza (59)
Intellectual property (103)
Interviews (813)
IPO (17831)
IRA (51)
Job creations (5190)
Job search strategy (2861)
Kidney cancer (11)
Labor market (47)
Layoffs (566)
Leadership (24)
Legal (10114)
Liver cancer (82)
Lung cancer (349)
Lymphoma (162)
Machine learning (9)
Management (65)
Manufacturing (373)
MASH (84)
Medical device (14644)
Medtech (14649)
Mergers & acquisitions (22456)
Metabolic disorders (812)
Multiple sclerosis (90)
NASH (23)
Neurodegenerative disease (119)
Neuropsychiatric disorders (34)
Neuroscience (2130)
NextGen: Class of 2025 (7682)
Non-profit (5082)
Now hiring (41)
Obesity (433)
Opinion (276)
Ovarian cancer (83)
Pain (105)
Pancreatic cancer (91)
Parkinson's disease (163)
Partnered (24)
Patents (259)
Patient recruitment (119)
Peanut (51)
People (65339)
Pharmaceutical (143)
Pharmacy benefit managers (22)
Phase I (22676)
Phase II (31913)
Phase III (24038)
Pipeline (1409)
Policy (181)
Postmarket research (3552)
Preclinical (10238)
Press Release (72)
Prostate cancer (114)
Psychedelics (38)
Radiopharmaceuticals (271)
Rare diseases (438)
Real estate (7392)
Recruiting (75)
Regulatory (26839)
Reports (58)
Research institute (2658)
Resumes & cover letters (649)
Rett syndrome (6)
RNA editing (5)
RSV (50)
Schizophrenia (82)
Series A (144)
Series B (94)
Service/supplier (30)
Sickle cell disease (59)
Special edition (20)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (4294)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (54)
The Weekly (83)
Vaccines (823)
Venture capitalists (45)
Weight loss (307)
Women's health (41)
Worklife (20)
Date
Today (65)
Last 7 days (1027)
Last 30 days (3205)
Last 365 days (35469)
2025 (12901)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (61)
Alaska (7)
Arizona (270)
Arkansas (14)
Asia (50174)
Australia (8835)
California (6701)
Canada (2109)
China (578)
Colorado (289)
Connecticut (307)
Delaware (169)
Europe (115140)
Florida (981)
Georgia (227)
Hawaii (1)
Idaho (64)
Illinois (641)
India (31)
Indiana (345)
Iowa (12)
Japan (178)
Kansas (113)
Kentucky (28)
Louisiana (15)
Maine (70)
Maryland (993)
Massachusetts (5121)
Michigan (253)
Minnesota (433)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (69)
New Hampshire (70)
New Jersey (1881)
New Mexico (31)
New York (1882)
North Carolina (1150)
North Dakota (9)
Northern California (2887)
Ohio (224)
Oklahoma (15)
Oregon (48)
Pennsylvania (1470)
Puerto Rico (14)
Rhode Island (36)
South America (1653)
South Carolina (26)
South Dakota (1)
Southern California (2487)
Tennessee (108)
Texas (1006)
United States (25589)
Utah (199)
Virginia (177)
Washington D.C. (72)
Washington State (617)
West Virginia (3)
Wisconsin (72)
There are 847,362 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AB Science reports its revenues for the year 2024 and provides an update on its activities
May 12, 2025
·
23 min read
Press Releases
Novo Nordisk A/S: Once-weekly Sogroya® (somapacitan) is an efficacious and well-tolerated long-acting growth hormone in children with growth disorders: results from REAL8 phase 3 basket study presented at the joint Congress of ESPE and ESE
May 12, 2025
·
8 min read
Press Releases
Nanobiotix to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ
May 12, 2025
·
1 min read
Press Releases
Faron Pharmaceuticals Presents Promising Phase 1/2 Data from BEXMAB Study at MDS 2025 Plenary Session
May 12, 2025
·
7 min read
Press Releases
Notice to the Annual General Meeting in IRLAB Therapeutics AB
May 12, 2025
·
1 min read
Press Releases
Alligator Bioscience to Attend ASCO 2025 Annual Meeting
May 12, 2025
·
2 min read
Press Releases
ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance
May 12, 2025
·
27 min read
Press Releases
Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Trial in the New England Journal of Medicine
May 12, 2025
·
7 min read
Press Releases
Anika Reports First Quarter 2025 Financial Results
May 12, 2025
·
15 min read
Press Releases
uniQure Announces First Quarter 2025 Financial Results and Highlights of Recent Company Progress
May 12, 2025
·
14 min read
1 of 84,737
Next
